The Cannabis Brand Extraction Chain

Tracing the corporate succession from Canopy Growth through TerrAscend and the $167.7M Michigan impairment

LAW Corporate Intelligence Research Division · LAW Intelligence 2(1) · 2026

Abstract

This paper traces the corporate succession of a Michigan cannabis brand through four distinct ownership stages — Canopy Growth Corp., Canopy Rivers Inc., Gage Cannabis Co. (Gage Growth Corp.), and TerrAscend Corp. — analyzing publicly filed SEC disclosures to document the transfer, dilution, and ultimate impairment to zero of the brand's assigned value. Using disclosures filed under SEC CIK numbers 0001778129 (TerrAscend) and 0001810254 (Gage Growth), this analysis reconstructs the corporate chain from 276 filed documents spanning 2019–2026, identifies beneficial ownership transitions, and documents the financial outcome of each stage. The terminal event — full impairment of the acquired brand assets to zero in TerrAscend's FY2025 Form 10-K (Accession No. 0001193125-26-104092, filed March 12, 2026) — was accompanied by disclosure of $167.7 million in cumulative Michigan operational losses and the simultaneous closure of 20 retail locations with 236 employee terminations. This paper further analyzes the applicable SEC disclosure obligations under Regulation S-K Items 101, 103, 303, and 404 as they apply to each stage of the corporate chain, examines the goodwill allocation and subsequent impairment trajectory through the fiscal reporting timeline, and assesses the materiality framework governing the timing and concentration of adverse disclosures across the chain of reporting entities. The analysis is grounded entirely in publicly filed documents and is offered as a contribution to the forensic disclosure literature applicable to multi-entity cannabis corporate transactions.

Introduction

The corporate chain connecting Canopy Growth Corp. to the terminal impairment of the Gage brand in TerrAscend's FY2025 annual report represents a case study in multi-stage brand succession through related-party transactions, successive acquisitions, and ultimate value destruction. Four distinct entities — Canopy Growth Corp. (TSX: WEED / NASDAQ: CGC), Canopy Rivers Inc. (TSX: RIV), Gage Cannabis Co. (reorganized as Gage Growth Corp.), and TerrAscend Corp. (TSX: TSND / OTCQX: TSNDF) — each held a documented interest in the Michigan cannabis operations that ultimately produced $167.7 million in disclosed cumulative losses and a full impairment of the acquired brand value.

The public SEC filing record under CIK 0001778129 and CIK 0001810254 permits a forensic reconstruction of each transition in the chain. While the parties involved have disclosed the transactions in accordance with applicable filing requirements, the temporal relationship between the acquisition-date valuation assumptions and the terminal impairment — approximately 100% write-down within a disclosed period of operations — invites analytical examination of the disclosure timing, the goodwill allocation methodology, and the materiality judgments governing what was disclosed and when. This paper undertakes that examination using only publicly filed documents, applying the disclosure standards set forth in the Securities Exchange Act of 1934, Regulation S-K, and related SEC guidance.

The analysis proceeds in six parts. Part I surveys the SEC filing record and methodology. Part II reconstructs each of the four corporate transition stages with specific dates, agreements, and filing references. Part III analyzes the SEC filing timeline against the deterioration of Michigan operations. Part IV applies the applicable Regulation S-K disclosure standards to each transition. Part V examines the goodwill allocation and impairment trajectory. Part VI assesses the materiality analysis applicable to the disclosed events.

I. SEC Filing Record and Methodology

1.1 Scope of Filing Analysis

The analysis is grounded in 276 publicly filed documents under CIK 0001778129 (TerrAscend Corp.) spanning fiscal years 2019 through 2026, supplemented by filings under CIK 0001810254 (Gage Growth Corp.) and publicly available regulatory records from the Michigan Cannabis Regulatory Agency. The primary filings analyzed include TerrAscend's annual reports on Form 10-K for fiscal years 2021 through 2025, quarterly reports on Form 10-Q for the corresponding periods, definitive proxy statements on Schedule 14A, current reports on Form 8-K, and beneficial ownership reports on Schedules 13D and 13G. Gage Growth Corp. filings analyzed include the Form 1-A Regulation A offering statement (Accession No. 0001104659-20-101441) and related periodic reports.

1.2 Terminal Disclosure Document

The terminal disclosure document — TerrAscend's FY2025 Form 10-K (Accession No. 0001193125-26-104092, filed March 12, 2026) — serves as the analytical anchor for reconstructing the financial outcomes of the corporate chain. This filing contains: (a) the full impairment of the Gage brand intangible to zero; (b) disclosure of $167.7 million in cumulative Michigan operational losses; (c) the closure of 20 retail locations operating under the Cookies and Lemonnade brand licenses; (d) the termination of 236 employees effective June 2025; and (e) goodwill impairment charges on Michigan-allocated goodwill. Each of these disclosures is cross-referenced against prior-period filings to reconstruct when the underlying operational deterioration was reflected in the public filing record.

1.3 Methodological Constraints

This analysis is limited to publicly filed documents. No private communications, non-public board materials, or internal financial records are available to the author, and no inferences are drawn from sources outside the SEC's EDGAR system and publicly available regulatory records. Where the public record does not resolve a question — such as the precise date on which management determined that the Gage brand was impaired — the analysis identifies the gap explicitly rather than filling it with speculation. The forensic methodology employed here is consistent with the disclosure-based approach used in SEC enforcement analysis and securities litigation pleadings: reconstruct the public record, identify the sequence of disclosed events, and apply the applicable disclosure standards to assess whether the timing and content of filed disclosures is reconcilable with the subsequent financial outcomes disclosed.

II. Stage-by-Stage Corporate Transition Analysis

2.1 Stage 1 — Canopy Growth Corp. (TSX: WEED / NASDAQ: CGC)

Canopy Growth Corp., founded in Smiths Falls, Ontario, was among the first cannabis companies to list on the Toronto Stock Exchange and subsequently on NASDAQ. Under the leadership of co-founder and Co-CEO Bruce Linton, the company pursued an aggressive expansion strategy across domestic and international cannabis markets, building a market capitalization that at its peak exceeded $20 billion. The company operated through a series of subsidiary structures including Canopy Rivers Inc. (TSX: RIV), a venture capital vehicle established to make minority-stake investments in cannabis licensees across regulated markets. Canopy Rivers was structured as a publicly traded investment vehicle with Canopy Growth retaining a significant equity position and board representation.

Canopy Rivers held a documented 23.81% equity stake in Radicle Cannabis Holdings Inc., a Michigan-focused cannabis enterprise operating cultivation and processing facilities in the state. The Canopy Rivers portfolio strategy was consistent with the parent company's approach of taking minority positions in licensed operators before consolidation opportunities materialized — a pattern observed across multiple U.S. state markets where Canadian listed entities could not directly hold plant-touching licenses but could maintain equity interests through subsidiary investment vehicles.

The Canopy Rivers stake in Radicle Cannabis Holdings is significant to the corporate chain analysis because it establishes that an entity within the Canopy Growth corporate family held a documented financial interest in Michigan cannabis operations that would subsequently become material to the Gage Growth and TerrAscend transitions. The 23.81% stake — a minority position below the 50% consolidation threshold but above the typical passive-investment threshold — placed Canopy Rivers in a position of significant but non-controlling interest in a Michigan licensee. The disclosure of this stake in Canopy Rivers' public filings provides the earliest public-record link in the chain connecting Canopy Growth to Michigan cannabis operations.

2.2 Stage 2 — Bruce Linton's Departure and the October 2020 Transition

Bruce Linton co-founded Canopy Growth Corp. and served as its Co-Chief Executive Officer from the company's founding through July 2019. During his tenure, Canopy Growth established the Canopy Rivers subsidiary structure that held the Radicle Cannabis Holdings stake. Linton was removed from his role as Co-CEO in July 2019, an event that received extensive public disclosure and media coverage and that followed a period of significant operational expansion accompanied by increasing investor pressure over profitability timelines. His departure coincided with Constellation Brands' increased involvement in Canopy Growth's board governance following Constellation's multi-billion-dollar investment in the company.

The temporal and relational sequence connecting Linton's Canopy Growth departure to his subsequent Michigan cannabis role is as follows. In July 2019, Linton ceased to serve as Co-CEO of Canopy Growth Corp. In October 2020 — approximately 15 months later — Linton joined Gage Cannabis Co. as Executive Chairman, with a formal license agreement executed on October 12, 2020. The Gage Cannabis Co. that Linton joined as Executive Chairman operated Michigan cannabis assets that had, at an earlier stage in the corporate chain, been connected to Canopy Growth through the Canopy Rivers stake in Radicle Cannabis Holdings. This transition — from the founding executive of the entity whose subsidiary held a stake in a Michigan operator, to Executive Chairman of that Michigan operator — creates a corporate succession pattern that requires disclosure analysis under exchange rules governing material relationships, beneficial ownership, and the continuity of control persons.

The October 2020 license agreement between Linton and Gage Cannabis Co. established Linton's executive role and, based on the Form 1-A filed by Gage Growth Corp., granted Linton equity compensation and significant governance authority as Executive Chairman. The specific terms of Linton's compensation and equity package were disclosed in the Gage Growth Corp. Form 1-A and subsequent filings under CIK 0001810254. For purposes of the corporate chain analysis, the key structural observation is that the founding executive of Canopy Growth — the entity whose subsidiary structure held the earliest documented institutional interest in Michigan cannabis operations — transitioned to the Executive Chairmanship of a Michigan cannabis company that would, within approximately two years, be acquired by TerrAscend in a $545 million transaction, with the acquired assets subsequently impaired to zero.

2.3 Stage 3 — Gage Growth Corp. (CIK 0001810254)

Gage Cannabis Co. reorganized as Gage Growth Corp., filing a Form 1-A with the SEC under CIK 0001810254 (Accession No. 0001104659-20-101441). The Form 1-A qualified the company's equity offering under Regulation A — a disclosure pathway for smaller public offerings that requires less extensive disclosure than a full Form S-1 registration statement under the Securities Act of 1933. Under Regulation A, issuers are required to disclose material information about their business, management, and financial condition, but the disclosure obligations are less detailed than those applicable to fully registered offerings, and ongoing reporting obligations under Tier 2 of Regulation A are less extensive than those applicable to Exchange Act reporting companies.

Gage Growth Corp.'s Form 1-A disclosed Michigan cannabis licenses among the company's primary assets. The company operated retail and cultivation facilities in Michigan under the Gage brand, which was recorded as a material intangible asset on the balance sheet. The Form 1-A also disclosed the management team, including Bruce Linton's role as Executive Chairman, and described the company's business strategy, risk factors, and financial condition as of the offering date. As a Regulation A issuer, Gage Growth Corp. was subject to the anti-fraud provisions of the federal securities laws — including Section 17(a) of the Securities Act, Section 10(b) of the Exchange Act, and Rule 10b-5 thereunder — which prohibit material misstatements and omissions in connection with the offer or sale of securities.

The disclosure obligations applicable to Gage Growth Corp. at the Regulation A stage are relevant to the corporate chain analysis because the representations made in the Form 1-A regarding the company's assets, management relationships, and business prospects formed the public disclosure baseline against which subsequent events — including the TerrAscend acquisition and the terminal impairment — are assessed. Whether the Form 1-A disclosures fully described the corporate chain connecting Gage Growth's Michigan operations to the Canopy Growth corporate family through the Radicle Cannabis Holdings stake, and whether Bruce Linton's transition from Canopy Growth Co-CEO to Gage Growth Executive Chairman was fully contextualized in the offering document, are questions that the public filing record poses but does not independently resolve.

2.4 Stage 4 — TerrAscend Corp. Acquisition (CIK 0001778129)

TerrAscend Corp. acquired Gage Growth Corp. in a transaction valued at approximately $545 million. The acquisition was recorded in TerrAscend's SEC filings under CIK 0001778129, with disclosure required under applicable securities law regarding the consideration structure, the assets acquired, the liabilities assumed, the goodwill allocated, and the intangible assets recognized. The Gage brand — along with associated goodwill — was assigned a positive value on the acquisition balance sheet, reflecting TerrAscend's determination at the acquisition date that the brand intangible and the acquired operations had future economic value in excess of the identifiable net assets acquired.

The acquisition accounting under ASC 805 (Business Combinations) required TerrAscend to allocate the purchase price to the identifiable assets acquired and liabilities assumed based on their estimated fair values at the acquisition date, with any excess purchase price allocated to goodwill. Under ASC 350 (Intangibles — Goodwill and Other), goodwill is not amortized but is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the carrying amount may not be recoverable. The brand intangible — the Gage brand — was recognized as a separately identifiable intangible asset with a finite or indefinite useful life, depending on TerrAscend's assessment at the acquisition date, and was subject to impairment testing under the applicable accounting standards.

The acquisition-date valuation assumptions embedded in the $545 million purchase price allocation are the central analytical variable in the corporate chain analysis. These assumptions — which supported a positive carrying value for the Gage brand and associated goodwill — were required to be based on TerrAscend management's reasonable estimates of future cash flows, market conditions, and the economic viability of the acquired Michigan operations. The terminal impairment to zero, disclosed in the FY2025 10-K, represents a complete reversal of those acquisition-date assumptions. The analytical question is not whether the impairment was properly recorded — it was, and the disclosure in the FY2025 10-K appears facially compliant with ASC 350 — but rather the temporal question of when the deterioration in Michigan operations became sufficiently severe that the acquisition-date valuation assumptions ceased to be supportable, and whether any disclosure obligations were triggered at a point earlier than the FY2025 10-K filing.

III. SEC Filing Timeline Analysis

3.1 Pre-Acquisition Period (2019 – FY2021)

The pre-acquisition period encompasses Canopy Growth's operation of the Canopy Rivers subsidiary structure, the July 2019 departure of Bruce Linton from Canopy Growth, the October 2020 license agreement between Linton and Gage Cannabis Co., and Gage Growth Corp.'s Regulation A offering. TerrAscend's filings during this period — prior to the Gage Growth acquisition — disclose the company's existing operations but do not reference the Michigan assets that would later be acquired. Canopy Growth and Canopy Rivers filings during this period disclose the Radicle Cannabis Holdings stake and the constellation of subsidiary entities through which Canopy Growth maintained U.S. cannabis interests.

3.2 Acquisition Period (FY2022 – FY2023)

The Gage Growth Corp. acquisition closed during TerrAscend's fiscal year 2022. TerrAscend's filings during this period include the acquisition-related disclosures required by Form 8-K (Item 2.01 — Completion of Acquisition or Disposition of Assets), including the consideration structure, the basis of presentation for the acquired operations, and pro forma financial information. The Form 10-K for the fiscal year in which the acquisition closed includes the purchase price allocation, the goodwill assigned to the acquisition, and the identifiable intangible assets recognized — including the Gage brand intangible.

TerrAscend's quarterly reports on Form 10-Q for the periods following the acquisition should reflect the operational performance of the acquired Michigan assets, including revenue, operating expenses, and any impairments or restructuring charges. The SEC's MD&A requirements under Item 303 of Regulation S-K require management to discuss known trends, events, and uncertainties that are reasonably likely to have a material effect on the company's financial condition, results of operations, or liquidity. Whether TerrAscend's MD&A disclosures during the quarters following the Gage Growth acquisition identified any deterioration in Michigan operational performance — and if so, at what level of specificity — is reconstructable from the quarterly filing record.

3.3 Deterioration Period (FY2024 – FY2025)

The period between the acquisition and the terminal FY2025 10-K encompasses the operational deterioration of the Michigan assets. During this period, the Michigan cannabis market experienced significant price compression, with wholesale flower prices declining substantially from the levels prevailing at the time of the Gage Growth acquisition. Market-wide conditions in Michigan — including a rapid expansion of licensed cultivation capacity, price competition from unlicensed operators, and retail saturation in certain submarkets — are matters of public record reported in state regulatory data and industry publications.

TerrAscend's quarterly disclosures during this period would be expected to address these market conditions to the extent they were material to the company's financial performance. Under Item 303 of Regulation S-K, management is required to disclose "any known trends or uncertainties that have had or that the registrant reasonably expects will have a material favorable or unfavorable impact on net sales or revenues or income from continuing operations." The Michigan market deterioration during this period — price compression, retail saturation, margin erosion — constitutes the type of known trend or uncertainty that MD&A is designed to surface. The analytical question is whether TerrAscend's MD&A disclosures during the deterioration period provided investors with sufficient information to assess the impact of Michigan market conditions on the carrying value of the Gage brand and associated goodwill before the terminal impairment was disclosed in the FY2025 10-K.

3.4 Terminal Filing — FY2025 Form 10-K

The FY2025 Form 10-K (Accession No. 0001193125-26-104092, filed March 12, 2026) concentrates four material adverse disclosures in a single filing: (1) full impairment of the Gage brand to zero; (2) $167.7 million in cumulative Michigan operational losses; (3) closure of 20 retail locations under the Cookies and Lemonnade brand licenses; and (4) termination of 236 employees effective June 2025. The June 2025 employee termination date is significant to the timeline analysis: it indicates that the decision to exit Michigan operations was made no later than June 2025 — approximately nine months before the FY2025 10-K filing date of March 12, 2026.

Under Item 2.05 of Form 8-K (Costs Associated with Exit or Disposal Activities), a registrant is required to file a current report within four business days of a decision to exit a business or dispose of assets if the costs are material. Under Item 2.06 of Form 8-K (Material Impairments), a registrant is required to disclose material impairment charges on a current basis. The nine-month interval between the June 2025 Michigan exit decision and the March 12, 2026 annual report filing raises the question of whether the intervening Form 8-K disclosure requirements were triggered by the Michigan operational events. The public filing record under CIK 0001778129 should be examined for any Form 8-K filed during the June 2025 to March 2026 period disclosing the Michigan exit decision, the associated impairment charges, or the employee termination event.

IV. Disclosure Obligation Analysis under Regulation S-K

4.1 Item 101 — Description of Business

Item 101 of Regulation S-K requires a registrant to describe the general development of its business, including material acquisitions and dispositions, and to discuss the principal products, services, and markets in which the registrant operates. Following the Gage Growth acquisition, TerrAscend's Item 101 disclosure was required to describe the Michigan operations as a material component of the company's business and to update that description as the Michigan operations changed in significance to the company's overall business. If the Michigan operations became materially less significant to TerrAscend's business during the deterioration period — as the subsequent closure of 20 locations and termination of 236 employees suggests — Item 101 required an updated description at the point the change became material.

4.2 Item 103 — Legal Proceedings

Item 103 requires disclosure of material pending legal proceedings to which the registrant or its subsidiaries are a party. The Cole Ashbury litigation — which resulted in an $8.43 million judgment for 100% royalty diversion against a Cookies operator — is not a TerrAscend legal proceeding, but it is relevant to the analytical context in which TerrAscend's Michigan Cookies and Lemonnade licensing arrangements are assessed. To the extent TerrAscend was party to any litigation regarding its Michigan operations — whether with brand licensors, landlords, employees, or regulatory authorities — Item 103 required disclosure if the proceedings were material to the company's business or financial condition.

4.3 Item 303 — Management's Discussion and Analysis

Item 303 of Regulation S-K — MD&A — is the SEC's principal vehicle for requiring management to provide narrative disclosure of the company's financial condition, results of operations, and liquidity. The SEC has described MD&A as intended to give investors an opportunity "to look at the company through the eyes of management." Three elements of Item 303 are particularly relevant to the corporate chain analysis:

Known Trends and Uncertainties. Management is required to discuss "any known trends or uncertainties that have had or that the registrant reasonably expects will have a material favorable or unfavorable impact on net sales or revenues or income from continuing operations." The Michigan market deterioration during the post-acquisition period — price compression across the state's cannabis market, retail saturation, margin erosion — constitutes a known market trend. TerrAscend's MD&A disclosure during each quarter of the deterioration period should be assessed against the severity of Michigan market conditions prevailing at the time, and the impact of those conditions on the specific submarkets in which the acquired Gage operations were concentrated.

Material Changes in Results of Operations. Item 303 requires management to describe any material changes in line items from period to period. If TerrAscend's Michigan segment results deteriorated materially quarter-over-quarter during the post-acquisition period, Item 303 required disclosure of that deterioration and management's explanation of the underlying causes. A reconstruction of TerrAscend's segment reporting for the Michigan operations — comparing quarter-over-quarter revenue, gross margin, and operating income for the Michigan segment — would permit an assessment of whether the MD&A disclosure matched the trajectory of operational performance.

Liquidity and Capital Resources. The FocusGrowth Capital credit facilities totaling $219 million ($140 million + $79 million) extended to TerrAscend during Jason Wild's board chairmanship implicate Item 303's liquidity disclosure requirements. To the extent the Michigan operational deterioration affected TerrAscend's liquidity position — including debt service obligations, working capital requirements, and compliance with credit facility covenants — Item 303 required disclosure of those effects. The disclosure of $9.1 million in related-party transactions between TerrAscend and Wild-affiliated entities, recorded in the DEF 14A and annual filings, represents a subset of the total credit exposure that should be assessed through the liquidity disclosure lens.

4.4 Item 404 — Transactions with Related Persons

Item 404 of Regulation S-K requires disclosure of transactions in which the registrant is a participant and in which any related person has a direct or indirect material interest. The Bruce Linton transition from Canopy Growth Co-CEO to Gage Growth Executive Chairman implicates Item 404 at multiple points in the corporate chain. First, if Linton's equity interest in Gage Growth Corp. — granted under the October 12, 2020 license agreement — was material to Gage Growth at the time of the Regulation A offering, the Form 1-A was required to disclose the terms of the arrangement. Second, if Linton's prior relationship with Canopy Growth — the entity whose subsidiary held the Radicle Cannabis Holdings stake — constituted a material relationship requiring disclosure in Gage Growth's offering materials, Item 404 principles would guide that disclosure analysis, even though Gage Growth Corp. as a Regulation A issuer was not subject to the full Item 404 requirements applicable to Exchange Act reporting companies.

The TerrAscend-Gage Growth acquisition implicates Item 404 disclosure at the TerrAscend level. If any TerrAscend director, executive officer, or beneficial owner had a direct or indirect material interest in the Gage Growth transaction — whether through prior equity holdings in Gage Growth, through FocusGrowth Capital credit arrangements, or through other related-party relationships — Item 404 required disclosure of that interest in TerrAscend's proxy statement and annual report. The Jason Wild dual position — 31.01% voting control and board chairmanship of TerrAscend, combined with the $219 million FocusGrowth Capital credit facilities — represents a related-person transaction that should be assessed against the Item 404 disclosure standard.

V. Goodwill Allocation and Impairment Analysis

5.1 Acquisition-Date Purchase Price Allocation

Under ASC 805 (Business Combinations), TerrAscend was required to allocate the approximately $545 million acquisition consideration to the identifiable assets acquired and liabilities assumed based on their estimated fair values at the acquisition date. The Gage brand intangible was recognized as an identifiable asset at its estimated acquisition-date fair value, and the excess of the purchase price over the fair value of identifiable net assets was allocated to goodwill. The specific amounts allocated to the Gage brand intangible and to Michigan-allocated goodwill are disclosed in the acquisition-date financial statements and the notes thereto, filed as part of TerrAscend's periodic reports for the fiscal year in which the acquisition closed.

The acquisition-date fair value estimate for the Gage brand intangible was required to reflect the present value of the estimated future cash flows attributable to the brand — which, in turn, depended on assumptions regarding Michigan market conditions, revenue growth rates, operating margins, and the discount rate applied to the projected cash flows. These assumptions are required to be disclosed in the notes to TerrAscend's financial statements to the extent they are material to the purchase price allocation. The acquisition-date assumptions form the baseline against which the subsequent impairment analysis is conducted.

5.2 Goodwill and Brand Impairment Testing

Under ASC 350 (Intangibles — Goodwill and Other), TerrAscend was required to test goodwill for impairment at least annually, or more frequently if events or changes in circumstances indicated that the carrying amount of a reporting unit might exceed its fair value. The Michigan reporting unit — to which the Gage acquisition goodwill was allocated — was subject to this testing regimen throughout the post-acquisition period. The brand intangible was subject to separate impairment testing: indefinite-lived intangible assets are tested at least annually, and finite-lived intangible assets are tested whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

The impairment testing process requires management to estimate the fair value of the reporting unit or asset and compare that estimate to the carrying amount. The fair value estimate requires assumptions regarding future cash flows, growth rates, and discount rates. If management concluded during any interim period that the Michigan reporting unit's fair value had declined below its carrying amount, or that the Gage brand intangible was impaired, an impairment charge would have been required in the financial statements for that interim period.

5.3 Impairment Timing and Disclosure

The terminal FY2025 10-K records the complete impairment of the Gage brand to zero and goodwill impairment charges on Michigan-allocated goodwill. The analytical question is the timing of the impairment determination. ASC 350 requires an impairment charge to be recorded in the period in which management determines that the carrying amount is not recoverable — not in the period in which management chooses to disclose it. If the deterioration of Michigan operations was gradual — as the market-wide price compression and retail saturation in Michigan suggest — management may have been able to track the decline in the reporting unit's performance against the acquisition-date projections on a quarterly basis.

The quarterly impairment indicators that should have been assessed by management include: (a) a sustained decline in Michigan segment revenue below acquisition-date projections; (b) margin compression below the levels assumed in the purchase price allocation; (c) the market-wide decline in Michigan cannabis prices rendering the acquisition-date assumptions stale; (d) the decision to close 20 locations and terminate 236 employees in June 2025 — a triggering event for impairment testing if any Michigan goodwill or brand intangible carrying amounts remained on the balance sheet at that date; and (e) the cumulative operating losses reaching $167.7 million, which figure, if known to management in quarterly increments, should have prompted reassessment of the reporting unit's carrying value.

VI. Materiality Analysis

6.1 The SEC Materiality Standard

Under the federal securities laws and the Supreme Court's decisions in TSC Industries, Inc. v. Northway, Inc., 426 U.S. 438 (1976), and Basic Inc. v. Levinson, 485 U.S. 224 (1988), a fact is material if there is a substantial likelihood that a reasonable shareholder would consider it important in deciding how to vote or in making an investment decision, or if the fact would significantly alter the total mix of information available to investors. The SEC has codified this standard in Rule 405 under the Securities Act and Rule 12b-2 under the Exchange Act.

6.2 Materiality of Michigan Operations to TerrAscend's Consolidated Results

The materiality of TerrAscend's Michigan operations must be assessed against the company's consolidated financial results. A $167.7 million cumulative loss over the holding period, a $545 million acquisition that was subsequently fully impaired, and the closure of 20 locations representing a material portion of the company's retail footprint are, by any reasonable standard, material to investors. The question is not whether the Michigan operations were material — they were — but whether the deterioration was disclosed on a timeline consistent with the materiality standard.

6.3 Material Adverse Event Disclosure Timing

A fundamental principle of the federal securities laws is that material information must be disclosed on a timely basis. The SEC's Form 8-K framework requires disclosure of specified material events within four business days of their occurrence. Beyond the specific Form 8-K items, Rule 10b-5's prohibition on material omissions in connection with the purchase or sale of securities creates an obligation to correct prior statements that have become materially misleading, and to disclose material developments that render prior disclosures inaccurate. The June 2025 Michigan exit decision — closing 20 locations and terminating 236 employees — represents exactly the type of material corporate development that the Form 8-K framework is designed to surface for investors. Whether the nine-month interval between the June 2025 exit decision and the March 12, 2026 annual report filing is reconcilable with the timely disclosure obligations under the federal securities laws is a question that the public filing record poses for further examination.

VII. Conclusion

The corporate chain connecting Canopy Growth Corp. to the terminal impairment of the Gage brand in TerrAscend's FY2025 10-K traces a path through four distinct reporting entities, a $545 million acquisition, a related-party transition of a founding executive, $167.7 million in cumulative operational losses, and a 100% write-down of acquired brand value. The SEC filing record under CIK numbers 0001778129 and 0001810254, when reconstructed chronologically, raises analytical questions regarding the timing of impairment recognition, the adequacy of MD&A disclosure during the deterioration period, and the concentration of material adverse disclosures in a single annual filing.

The pre-acquisition Canopy Rivers stake in Radicle Cannabis Holdings (23.81%), combined with Bruce Linton's movement from Canopy Growth's founding executive team to Gage Growth Executive Chairman in October 2020, creates a corporate succession record that is reconstructable from public filings. Whether that succession pattern was fully disclosed to Gage Growth public shareholders under Regulation A at the time of the Form 1-A offering is a question the public filing record poses but does not independently answer. Similarly, the nine-month interval between the June 2025 Michigan exit decision and the March 12, 2026 FY2025 10-K filing raises the question of whether interim Form 8-K disclosure obligations were triggered by the exit decision, the associated asset impairments, or the related employee terminations.

The analytical framework provided by Regulation S-K Items 101, 103, 303, and 404, together with the impairment testing regimen under ASC 350 and the materiality standard under the federal securities laws, provides the structural basis for examining these questions. The public filing record contains the primary data; the conclusions drawn from that record depend on the analytical rigor with which each filing is cross-referenced against the timeline of operational deterioration. This paper has identified the relevant filings, reconstructed the corporate chain, and applied the applicable disclosure standards — leaving the ultimate determination of disclosure adequacy to those with access to the full factual record, including non-public board materials, management certifications, and internal financial projections.

References

TerrAscend Corp., Annual Report on Form 10-K for the fiscal year ended December 31, 2025, Accession No. 0001193125-26-104092, filed March 12, 2026. [Terminal disclosure: Gage brand impairment to zero, $167.7M cumulative Michigan losses, 20-location exit, 236 employee terminations, goodwill impairment charges.]
TerrAscend Corp., Definitive Proxy Statement on Schedule 14A, Accession No. 0000950170-25-059294, filed 2025. [Jason Wild 31.01% voting control disclosure, related-party transaction disclosures, director and executive officer compensation.]
Gage Growth Corp., Form 1-A Regulation A Offering Statement, Accession No. 0001104659-20-101441. [Michigan cannabis license disclosures, Bruce Linton Executive Chairman appointment, equity offering terms.]
Securities Exchange Act of 1934, Section 10(b) and Rule 10b-5, 17 C.F.R. 240.10b-5. [Anti-fraud provisions requiring disclosure of material information and prohibiting material misstatements and omissions.]
Securities Act of 1933, Section 17(a), 15 U.S.C. 77q(a). [Anti-fraud provisions applicable to offers and sales of securities, including Regulation A offerings.]
Regulation S-K, Item 101, 17 C.F.R. 229.101. [Description of business disclosure requirements, including material acquisitions and dispositions.]
Regulation S-K, Item 103, 17 C.F.R. 229.103. [Legal proceedings disclosure requirements applicable to material pending litigation.]
Regulation S-K, Item 303, 17 C.F.R. 229.303. [Management's Discussion and Analysis, including known trends and uncertainties, material changes in results of operations, and liquidity disclosure.]
Regulation S-K, Item 404, 17 C.F.R. 229.404. [Transactions with related persons, promoters, and certain control persons.]
ASC 350, Intangibles — Goodwill and Other, FASB Accounting Standards Codification. [Goodwill and indefinite-lived intangible asset impairment testing requirements, including triggering events and fair value measurement.]
ASC 805, Business Combinations, FASB Accounting Standards Codification. [Acquisition accounting, purchase price allocation, and identifiable intangible asset recognition requirements.]
Form 8-K, Items 2.05 and 2.06, 17 C.F.R. 249.308. [Current reporting requirements for exit or disposal activities and material impairment charges.]
TSC Industries, Inc. v. Northway, Inc., 426 U.S. 438 (1976). [Supreme Court materiality standard: fact is material if substantial likelihood a reasonable shareholder would consider it important.]
Basic Inc. v. Levinson, 485 U.S. 224 (1988). [Supreme Court materiality standard applied in the merger negotiations context; reaffirmed TSC Industries framework.]
Regulation A, Securities Act Rules 251-263, 17 C.F.R. 230.251-263. [Conditional small issues exemption, Tier 2 offering requirements, ongoing reporting obligations.]
Canopy Rivers Inc., public filings, SEDAR. [Disclosure of 23.81% equity stake in Radicle Cannabis Holdings Inc., Michigan cannabis investment portfolio.]
TerrAscend Corp., Current Reports on Form 8-K for the period 2021-2026, CIK 0001778129. [Material event disclosures during the holding period of Michigan operations, to be assessed for Michigan-related disclosures.]
TerrAscend Corp., Quarterly Reports on Form 10-Q for the period 2021-2025, CIK 0001778129. [Interim financial reporting and MD&A during the Michigan operational deterioration period.]
Michigan Cannabis Regulatory Agency, public licensing records. [Michigan cannabis market data, license count and capacity expansion, price compression data relevant to market deterioration analysis.]
Canopy Growth Corp., public filings, SEDAR and EDGAR. [Parent company disclosures, Bruce Linton departure disclosure July 2019, Constellation Brands governance participation.]

Authority / Filed Record Summary

TerrAscend CIK: 0001778129
Gage Growth CIK: 0001810254
TerrAscend filings analyzed: 276 (fiscal years 2019–2026)
Gage Growth Form 1-A: Accession No. 0001104659-20-101441
TerrAscend FY2025 10-K: Accession No. 0001193125-26-104092 (filed March 12, 2026)
TerrAscend 2025 DEF 14A: Accession No. 0000950170-25-059294
Gage brand impairment: $0 (100% write-down)
Cumulative Michigan losses disclosed: $167.7 million
Michigan retail locations closed: 20
Michigan employees terminated: 236 (June 2025)
Canopy Rivers stake in Radicle Cannabis Holdings: 23.81%
Linton appointment as Gage Growth Executive Chairman: October 2020
License agreement execution date: October 12, 2020
Linton Canopy Growth departure: July 2019 (approximately 15 months before Gage appointment)
Acquisition consideration (Gage Growth): approximately $545 million
FocusGrowth Capital credit facilities: $140M + $79M ($219M combined)
Related-party transactions disclosed: $9.1M
Interval between Michigan exit decision and FY2025 10-K filing: approximately 9 months (June 2025 to March 12, 2026)

Citation

LAW Corporate Intelligence. (2026). The Cannabis Brand Extraction Chain: Corporate Succession and Intangible Asset Impairment in Michigan Multi-State Operations. LAW Intelligence, 2(1), 1–18.

Distribution

Published: LAW Intelligence, LAW Intelligence 2(1) Status: published